Ascitic Fluid from Human Ovarian Cancer Patients Contains Growth Factors Necessary for Intraperitoneal Growth of Human Ovarian Adenocarcinoma Cells

作者: G B Mills , C May , M Hill , S Campbell , P Shaw

DOI: 10.1172/JCI114784

关键词: Nude mouseOvarian cancerGrowth factorAdenocarcinomaAscitesOvaryCystadenocarcinomaPathologyPeritoneal cavityMedicine

摘要: Human ovarian cancer, the leading cause of death from gynecologic malignancy, tends to remain localized peritoneal cavity until late in disease. In established disease, ascitic fluid accumulates cavity. We have previously demonstrated that this is a potent source vitro mitogenic activity including at least one unique growth factor. now report human adenocarcinoma line, HEY, can be induced grow intraperitoneally immunodeficient nude mice presence (23/28 mice), but not absence (0/21 mice) cancer patients. Ascitic patients with benign disease did similar effects on intraperitoneal HEY cells (1/15 mice). Once tumors were by injections exogenous fluid, they could progress additional fluid. The eventually developed which contained factor activity, suggesting produced autologous factors. This mouse model provides system study action factors tumor vivo and evaluate preclinically, therapeutic approaches designed counteract these

参考文章(9)
J. M. Trent, R. N. Buick, R. Pullano, Comparative Properties of Five Human Ovarian Adenocarcinoma Cell Lines Cancer Research. ,vol. 45, pp. 3668- 3676 ,(1985)
Chaim M. Roifman, Alan Mellors, Gordon B. Mills, Christopher May, Martha McGill, A Putative New Growth Factor in Ascitic Fluid from Ovarian Cancer Patients: Identification, Characterization, and Mechanism of Action Cancer Research. ,vol. 48, pp. 1066- 1071 ,(1988)
C. A. Y. Seipp, M. C. Custer, S. E. Ettinghausen, S. O. Sharrow, S. A. Rosenberg, A. A. Rayner, M. T. Lotze, Y. L. Matory, In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. Journal of Immunology. ,vol. 135, pp. 2865- 2875 ,(1985)
P. Shaw, R. Buckman, J. Law, R. Baumal, A. Marks, Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies. Tumor Biology. ,vol. 9, pp. 101- 109 ,(1988) , 10.1159/000217550
Michael B. Sporn, Anita B. Roberts, Autocrine growth factors and cancer. Nature. ,vol. 313, pp. 745- 747 ,(1985) , 10.1038/313745A0
Katherine Sheldon, Alexander Marks, Reuben Baumal, Characterization of binding of four monoclonal antibodies to the human ovarian adenocarcinoma cell line HEY Biochemistry and Cell Biology. ,vol. 65, pp. 423- 428 ,(1987) , 10.1139/O87-054
George S. Richardson, Robert E. Scully, Najamosama Nikrui, James H. Nelson, Common Epithelial Cancer of the Ovary New England Journal of Medicine. ,vol. 312, pp. 415- 424 ,(1985) , 10.1056/NEJM198502143120706
Reuben Baumal, Alexander Marks, Katherine Sheldon, Herman Yeger, Harriette Kahn, Terry Colgan, John Law, Ronald N. Buick, Monoclonal Antibodies to an Epithelial Ovarian Adenocarcinoma: Distinctive Reactivity with Xenografts of the Original Tumor and a Cultured Cell Line Cancer Research. ,vol. 46, pp. 3994- 4000 ,(1986)
H E Varmus, The Molecular Genetics of Cellular Oncogenes Annual Review of Genetics. ,vol. 18, pp. 553- 612 ,(1984) , 10.1146/ANNUREV.GE.18.120184.003005